AquaBounty Technologies (NASDAQ:AQB) Posts Earnings Results

AquaBounty Technologies (NASDAQ:AQB) posted its earnings results on Thursday. The company reported ($0.20) earnings per share for the quarter, Zacks reports.

AquaBounty Technologies Price Performance

Shares of AquaBounty Technologies stock traded down $0.01 during trading hours on Friday, reaching $0.94. The company’s stock had a trading volume of 27,687 shares, compared to its average volume of 34,129. The firm has a 50 day moving average price of $0.94 and a 200-day moving average price of $0.98. AquaBounty Technologies has a one year low of $0.63 and a one year high of $2.95. The stock has a market cap of $4.84 million, a P/E ratio of -1.13 and a beta of 1.36.

Institutional Trading of AquaBounty Technologies

A hedge fund recently raised its stake in AquaBounty Technologies stock. Renaissance Technologies LLC increased its position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 121,585 shares of the company’s stock after purchasing an additional 92,065 shares during the period. Renaissance Technologies LLC owned approximately 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent quarter. 8.92% of the stock is currently owned by institutional investors and hedge funds.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.